United States Personal Protective Equipment Market Outlook to 2033 - Gloves, Gowns, Masks, Shoe Covers and Others - Gloves,
Summary
GlobalData’s “United States Personal Protective Equipment Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United States Personal Protective Equipment market.
The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Examination Table Papers, Face Shields, Gloves, Gowns, Masks, and Shoe Covers
The United States Personal Protective Equipment Market report provides key information and data on -
Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
2023 company share and distribution share data for Personal Protective Equipment Market.
Global corporate-level profiles of key companies operating within the United States Personal Protective Equipment Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope
United States Personal Protective Equipment is segmented as follows -
Examination Table Papers
Face Shields
Gloves
Gowns
Masks
Shoe Covers
Reasons to Buy
The United States Personal Protective Equipment Market report helps you to develop -
Business strategies by identifying the key market segments poised for strong growth in the future.
Market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Personal Protective Equipment Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Personal Protective Equipment Market, United States
3.1 Personal Protective Equipment Market, United States, Revenue ($m), 2018-2033
3.1.1 Gloves Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.2 Masks Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Personal Protective Equipment Market, United States, Volume (Units), 2018-2033
3.2.1 Gloves Market, United States, Volume (Units), by Segment, 2018-2033
3.2.2 Masks Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Personal Protective Equipment Market, United States, Average Price ($), 2018-2033
3.4 Personal Protective Equipment Market, United States, Distribution Share by Revenue ($m), 2023
3.5 Personal Protective Equipment Market, United States, Company Share by Revenue ($m), 2023
4 Overview of Key Companies in United States, Personal Protective Equipment Market
4.1 Cardinal Health Inc
4.1.1 Company Overview
4.2 Owens & Minor Inc
4.2.1 Company Overview
4.3 Medline Industries LP
4.3.1 Company Overview
4.4 Molnlycke Health Care AB
4.4.1 Company Overview
4.5 Henry Schein Inc
4.5.1 Company Overview
4.6 3M Co
4.6.1 Company Overview
4.7 TIDI Products LLC
4.7.1 Company Overview
4.8 Ansell Limited
4.8.1 Company Overview
5 Personal Protective Equipment Market Pipeline Products
6 Financial Deals Landscape
6.1 Acquisition
6.1.1 Getinge Acquires 100% Stake in Healthmark Industries for Approximately USD320 Million
6.2 Debt Offerings
6.2.1 Becton, Dickinson and Co Raises USD600 Million in Public Offering of 5.081% Notes due 2029
6.2.2 Becton Dickinson Raises USD1.09 Billion in Public Offering of 3.828% Notes due 2032
6.2.3 Cardinal Health Raises USD650 Million in Public Offering of 5.125% Notes Due 2029
6.2.4 Cardinal Health Raises USD500 Million in Public Offering of 5.45% Notes Due 2034
6.2.5 Becton, Dickinson and Company (Becton Dickinson and Co) Raises USD625 Million in Public Offering of 4.874% Notes Due 2029
7 Recent Developments
7.1 Corporate Communications
7.1.1 Aug 17, 2024: Abiomed Receives Additional FDA 510(k) Clearance for Low Profile Introducer Set 14Fr
7.1.2 Aug 01, 2024: 3M Names Anurag Maheshwari as Executive Vice President and Chief Financial Officer
7.2.4 Jul 17, 2024: Baxter to Host Second-Quarter 2024 Financial Results Conference Call for Investors
7.2.5 Jul 15, 2024: Integra LifeSciences to Host Second Quarter 2024 Financial Results Conference Call on July 29, 2024
7.2.6 Jul 08, 2024: Henry Schein to Webcast Second Quarter 2024 Conference Call on Tuesday, August 6, 2024 at 10:00 a.m. ET
7.2.7 Apr 30, 2024: 3M First-Quarter Results Driven by Strong Operational Performance; Company Initiates Full-Year 2024 Guidance Reflecting Completion of Solventum Spin
7.2.8 Jan 04, 2024: Baxter to Host Fourth-Quarter 2023 Financial Results Conference Call for Investors
7.2.9 Nov 08, 2023: ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide a Corporate Strategic Update
7.2.10 Nov 03, 2023: Cardinal Health Reports First Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook
7.2.11 Oct 24, 2023: 3M Reports Third Quarter 2023 Results; Company Increases Full Year Adjusted Earnings and Cash Flow Expectations
7.2.12 Sep 19, 2023: Baxter to Host Third-Quarter 2023 Financial Results Conference Call for Investors
7.3 Government and Public Interest
7.3.1 May 21, 2024: FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
7.3.2 May 21, 2024: Henry Schein to Present at Investor Conferences in June 2024
7.3.3 May 07, 2024: Baxter to Present at Bank of America 2024 Health Care Conference
7.3.4 Jan 03, 2024: Henry Schein to Present at J.P. Morgan’s Healthcare Investor Conference
7.3.5 Nov 14, 2023: BD to Present at the 6th Annual Evercore ISI HealthCONx Conference
7.3.6 Nov 07, 2023: Henry Schein to Present at Upcoming Investor Conferences in November 2023
7.3.7 Sep 06, 2023: ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference
7.4 Legal And Regulatory
7.4.1 Apr 24, 2024: Ascentage Pharma to Present Data on APG-2449 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
7.5 Other Significant Developments
7.5.1 Oct 16, 2023: Astellas to Share New Data from Enfortumab Vedotin During ESMO Congress 2023
7.6 Strategy And Business Planning
7.6.1 Jun 13, 2024: Pall Corporation opens regional hub in Singapore
8. Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 GlobalData Consulting
8.3 Contact Us
8.4 Disclaimer
List of Tables
Table 1: Personal Protective Equipment Market, United States, Revenue ($m), USD Constant, 2018-2033